Related Experiment Videos
Isoimmunization to Cromer antigen in pregnancy
1Department of Obstetrics and Gynecology, Kaiser Foundation Hospital, Bellflower, CA.
American Journal of Obstetrics and Gynecology
|October 1, 1989
Summary
Pregnancy with anti-Cromer antigen antibodies is reported. Fortunately, her infants were unaffected by hemolytic disease of the newborn, suggesting potential safe outcomes in similar cases.
Area of Science:
- Immunology
- Obstetrics
- Transfusion Medicine
Background:
- Cromer antigen is a high-frequency blood group antigen.
- Isoimmunization to Cromer antigen during pregnancy can pose risks.
- Hemolytic disease of the newborn (HDN) is a potential complication.
Observation:
- A case of pregnancy in a woman with anti-Cromer antigen antibodies is presented.
- The woman had two previous infants who were positive for the Cromer antigen.
- Neither of these infants developed hemolytic disease of the newborn.
Findings:
- The absence of HDN in Cromer antigen-positive infants despite maternal isoimmunization suggests a potentially lower risk than anticipated for this specific antigen.
- This case highlights the variability in clinical outcomes for RhD-negative mothers carrying RhD-positive fetuses with specific high-frequency antigen incompatibilities.
- Further investigation into the immunogenicity and clinical significance of Cromer antigen antibodies is warranted.
Implications:
- Autologous or compatible donor blood (Cromer antigen-negative) should be considered for cryopreservation and storage for potential transfusion needs in such pregnancies.
- This approach provides a proactive measure for managing potential transfusion requirements during pregnancy or delivery.
- The findings may influence clinical management strategies and transfusion protocols for pregnant women with rare blood group antibodies.